Literature DB >> 14675288

Proximal-type epithelioid sarcoma: case report and result of comparative genomic hybridization.

Mi-Woo Lee1, Kowan-Ja Jee, Jae-Yoon Ro, Deuk-Pyo Lee, Jee-Ho Choi, Kee-Chan Moon, Jai-Kyoung Koh.   

Abstract

BACKGROUND: Epithelioid sarcoma is a rare mesenchymal neoplasm. Recently, a more aggressive, so-called "proximal type" epithelioid sarcoma has been described. CLINICAL CASE: A 40-year-old-woman presented with 5 x 4 cm, erythematous, indurated, non-movable, painful mass on the pubic area. Histopathology demonstrated diffuse tumor-cell infiltration into the subcutaneous and fascia, which was consisted of prominent epithelioid cells and scattered rhabdoid cells. A multinodular growth pattern or granulomatous appearance with central necrosis was not observed. The tumor cells showed positive reactions for vimentin, cytokeratin (AE1/AE3), and CD34. Despite the surgery, left inguinal mass with lymphadenopathy occurred one month later. We also carried out comparative genomic hybridization (CGH) with tumor cells. CGH revealed chromosomal gain of 5q32-qter, 12q24-qter, and 22q.
CONCLUSION: We report a case of proximal-type of epithelioid sarcoma, which showed the chromosomal gains of 5q32-qter, 12q24-qter, and 22q by CGH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675288     DOI: 10.1046/j.0303-6987.2004.0136.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  Proximal-type epithelioid sarcoma -- case report.

Authors:  Luciana Mendes dos Santos; Lisiane Nogueira; Christiane Yuri Matsuo; Carolina Talhari; Mônica Santos
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

2.  Proximal-type epithelioid sarcoma--a rare, aggressive subtype of epithelioid sarcoma presenting as a recurrent perineal mass in a middle-aged male.

Authors:  Bharat Rekhi; Biru D Gorad; Roshni F Chinoy
Journal:  World J Surg Oncol       Date:  2007-03-06       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.